文献速递血管炎

ANCA相关血管炎发病年龄与临床表现及短期结局的关联

Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

基于DCVAS队列1338例ANCA相关血管炎患者,按诊断年龄<65岁或≥65岁分组,并校正AAV类型和ANCA类型。老年组MPO-ANCA阳性更常见,系统、神经、心血管受累及肾功能恶化更多,6个月VDI≥5比例更高,且老年是6个月内早期死亡的独立危险因素。

要点

  • 老年起病AAV患者MPO-ANCA阳性率更高,系统、神经、心血管受累及肾功能恶化更常见。
  • 老年起病者6个月时显著损伤累积(VDI≥5)比例更高,早期死亡风险增加。
  • 年轻起病者肌肉骨骼、皮肤和耳鼻喉表现更常见,临床表型存在年龄差异。

核心结论

  • 诊断后6个月内,>65岁AAV患者器官受累模式不同,显著损伤和死亡风险高于年轻患者。

研究设计与样本

  • 纳入2010年10月至2017年1月DCVAS研究中确诊AAV的患者,按诊断年龄<65岁或≥65岁分组,并校正AAV类型和ANCA类型。

主要发现

  • 共纳入1338例AAV患者,66%起病年龄<65岁(女性50%;平均年龄48.4岁,s.d. 12.6),34%起病年龄≥65岁(女性54%;平均年龄73.6岁,s.d. 6)。
  • 老年组MPO-ANCA阳性更常见(48% vs 27%;P=0.001)。
  • 年轻患者肌肉骨骼、皮肤和耳鼻喉表现发生率更高,老年组系统、神经、心血管受累及肾功能恶化更常见。
  • 老年患者6个月VDI≥5比例为12%,年轻患者为7%(P=0.01)。
  • 老年年龄是诊断后6个月内早期死亡的独立危险因素(HR 2.06,95%CI 1.07-3.97;P=0.03)。

临床怎么用

  • 对≥65岁起病的AAV患者应警惕更高的系统、神经、心血管及肾脏受累风险,并密切监测早期死亡和损伤累积。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: ANCA-associated vasculitis (AAV) can affect all age groups. We aimed to show that differences in disease presentation and 6 month outcome between younger- and older-onset patients are still incompletely understood. METHODS: We included patients enrolled in the Diagnostic and Classification Criteria for Primary Systemic Vasculitis (DCVAS) study between October 2010 and January 2017 with a diagnosis of AAV. We divided the population according to age at diagnosis: <65 years or ≥65 years. We adjusted associations for the type of AAV and the type of ANCA (anti-MPO, anti-PR3 or negative). RESULTS: A total of 1338 patients with AAV were included: 66% had disease onset at <65 years of age [female 50%; mean age 48.4 years (s.d. 12.6)] and 34% had disease onset at ≥65 years [female 54%; mean age 73.6 years (s.d. 6)]. ANCA (MPO) positivity was more frequent in the older group (48% vs 27%; P = 0.001). Younger patients had higher rates of musculoskeletal, cutaneous and ENT manifestations compared with older patients. Systemic, neurologic,cardiovascular involvement and worsening renal function were more frequent in the older-onset group. Damage accrual, measured with the Vasculitis Damage Index (VDI), was significantly higher in older patients, 12% of whom had a 6 month VDI ≥5, compared with 7% of younger patients (P = 0.01). Older age was an independent risk factor for early death within 6 months from diagnosis [hazard ratio 2.06 (95% CI 1.07, 3.97); P = 0.03]. CONCLUSION: Within 6 months of diagnosis of AAV, patients >65 years of age display a different pattern of organ involvement and an increased risk of significant damage and mortality compared with younger patients.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Monti S, Craven A, Klersy C, et al. Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes. Rheumatology (Oxford). 2021. PMID: 32447389. doi:10.1093/rheumatology/keaa215

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。